BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30411430)

  • 1. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
    Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
    J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
    Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
    J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal-specific IgG levels after 13-valent pneumococcal conjugate vaccination in Nigerian children with sickle cell disease.
    Disu EA; Akodu SO; Arinola OG; Diaku-Akinwumi IN; Adedokun B; Olopade CO; Njokanma OF
    Paediatr Int Child Health; 2016 Nov; 36(4):296-299. PubMed ID: 26745438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine.
    Alexander E; Telfer P; Rashid H; Ali KA; Booy R
    J Infect Public Health; 2008; 1(1):40-4. PubMed ID: 20701844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening.
    Hardie R; King L; Fraser R; Reid M
    Ann Trop Paediatr; 2009 Sep; 29(3):197-202. PubMed ID: 19689861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccination rates in children with sickle cell disease.
    Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
    J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease.
    Santoro JD; Myers L; Kanter J
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e102-6. PubMed ID: 26886376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timeliness and risk factors associated with delay for pneumococcal conjugate 10-valent routine immunization in Brazilian children.
    Sartori AL; Minamisava R; Afonso ET; Policena GM; Pessoni GC; Bierrenbach AL; Andrade AL
    Vaccine; 2017 Feb; 35(7):1030-1036. PubMed ID: 28108230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era.
    Martin OO; Moquist KL; Hennessy JM; Nelson SC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
    De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA
    Pediatr Blood Cancer; 2015 Aug; 62(8):1427-36. PubMed ID: 25810327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of pneumococcal infection in sickle-cell disease by the combined use of vaccination and penicillin.
    Babiker MA
    Ann Trop Paediatr; 1986 Sep; 6(3):179-81. PubMed ID: 2430506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunisation coverage, 2012.
    Hull BP; Dey A; Menzies RI; Brotherton JM; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E208-31. PubMed ID: 25391407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
    Cameron C; Pebody R
    Euro Surveill; 2006 Mar; 11(3):E060302.4. PubMed ID: 16804223
    [No Abstract]   [Full Text] [Related]  

  • 20. A community-based cross-sectional immunisation survey in parents of primary school students.
    Hon KL; Tsang YC; Chan LC; Ng DK; Miu TY; Chan JY; Lee A; Leung TF;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16011. PubMed ID: 27053378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.